Home | Business News | Browse by Publication | S | San Diego Business Journal

Drug OK adds to Halozyme's success story: Diversa announces expansion with Merck to develop new antibodies.

Publication: San Diego Business Journal
Publication Date: 27-JUN-05
Format: Online
Delivery: Immediate Online Access
Full Article Title: Drug OK adds to Halozyme's success story: Diversa announces expansion with Merck to develop new antibodies.(BIOTECH)(Halozyme Therapeutics Inc.)(Brief Article)

Article Excerpt
Sorrento Valley-based Halozyme Therapeutics Inc. has hit another goal.

On June 20, the publicly traded biotechnology firm announced the launch of its first approved product, Cumulase, a human-based enzyme used for preparing eggs for in vitro fertilization procedures.

The company won Food and Drug Administration marketing approval for Cumulase...

Access Full Article, Compliments of Goliath

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.